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Abstract
The lowest possible energy of proton scanning beam in cyclotron proton therapy facilities is
typically between 60 and 100 MeV. Treatment of superficial lesions requires a pre-absorber to
deliver doses to shallower volumes. In most of the cases a range shifter (RS) is used, but as an
alternative solution, a patient-specific 3D printed proton beam compensator (BC) can be applied.
A BC enables further reduction of the air gap and consequently reduction of beam scattering. Such
pre-absorbers are additional sources of secondary radiation. The aim of this work was the
comparison of RS and BC with respect to out-of-field doses for a simulated treatment of superficial
paediatric brain tumours. EURADOSWG9 performed comparative measurements of scattered
radiation in the Proteus C-235 IBA facility (Cyclotron Centre Bronowice at the Institute of Nuclear
Physics, CCB IFJ PAN, Kraków, Poland) using two anthropomorphic phantoms—5 and 10 yr
old—for a superficial target in the brain. Both active detectors located inside the therapy room, and
passive detectors placed inside the phantoms were used. Measurements were supplemented by
Monte Carlo simulation of the radiation transport. For the applied 3D printed pre-absorbers,
out-of-field doses from both secondary photons and neutrons were lower than for RS.
Measurements with active environmental dosimeters at five positions inside the therapy room
indicated that the RS/BC ratio of the out-of-field dose was also higher than one, with a maximum
of 1.7. Photon dose inside phantoms leads to higher out-of-field doses for RS than BC to almost all
organs with the highest RS/BC ratio 12.5 and 13.2 for breasts for 5 and 10 yr old phantoms,
respectively. For organs closest to the isocentre such as the thyroid, neutron doses were lower for
BC than RS due to neutrons moderation in the target volume, but for more distant organs like
bladder—conversely—lower doses for RS than BC were observed. The use of 3D printed BC as the
pre-absorber placed in the near vicinity of patient in the treatment of superficial tumours does not
result in the increase of secondary radiation compared to the treatment with RS, placed far from
the patient.
© 2021 Institute of Physics and Engineering inMedicine
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1. Introduction
Proton therapy (PT) is a modern method of radiotherapy using proton beams of energies up to 250 MeV, in
which a steady increase in the number of patients and emerging centres offering this type of treatment is
observed. One of the main arguments for the application of PT is favourable dose distributions, because
protons deposit maximum energy at the end of their path. That feature allows the achievement of improved
precision of the dose delivery while reducing the risk of damage to critical organs and healthy tissue
surrounding the lesion (Tian et al 2018). Out-of-field doses from scattered radiation absorbed by normal
tissues increase the probability of late effects including the generation of secondary cancers, particularly in
children (Packer et al 2013). Neutron doses are of special concern because of their high biological
effectiveness (Valentin 2003).
Undesirable doses to healthy tissues distant from the target volume largely depend on the beam delivery
technique. In PT facilities with double beam scattering techniques, a significant secondary neutron
component is generated in the beam forming elements (Stolarczyk et al 2011, Bonfrate et al 2016). This
disadvantage has been considerably reduced with the introduction of pencil beam scanning (PBS)
technology. The beam is steered by magnets and only thin beam monitoring chambers and a vacuum foil
intercept the proton trajectories. Currently, practically all newly installed PT facilities are equipped with the
PBS system. In cyclotrons, the proton beam is extracted at the maximal energy of 230 MeV (IBA, Sumitomo)
or 250 MeV (Varian) and then the beam energy is reduced by an energy degrader and energy selector to
adapt the beam energy to the required range.
In PT of children, compared with adults, special attention is given to the treatment of shallowly-located
tumours. For young children, lesions might be located closer than a few centimetres beneath the patient’s
skin. In facilities with PBS technology, the lowest energy of the proton beam ranges typically between 60 and
100 MeV, which corresponds to a range of about 3.1–7.5 cm in water-equivalent thickness. The irradiation of
superficial lesions requires the application of a pre-absorber, which reduces proton range. Typically a plate of
poly(methyl methacrylate) (PMMA) or Lexan acting as a range shifter (RS) is attached to the nozzle at a
certain distance from the patient’s body and used to deliver shallower spots (Gillin et al 2010, Matysiak et al
2016). Increasing the distance between the RS and the patient’s body increases the spot size and penumbra
(Titt et al 2010, Shen et al 2015, Baumer et al 2018). To mitigate this effect, some PBS nozzles offer the
possibility of minimizing the air gap by using a movable snout extension and bringing the RS closer to the
patient (Pedroni et al 2005, Shen et al 2015, Matysiak et al 2016). However, the fixed shape of the RS plate
makes it impossible to completely eliminate the air gap and requires special care to avoid collision with the
patient. For nozzles without a movable RS, treatment of shallow tumours with high precision is significantly
more difficult.
One of the solutions suggested in the literature is the use of a pre-absorber that will adhere exactly to the
patient’s body. Such a compensator should be designed and manufactured for each individual patient.
Moreover, the thickness and final shape could also be adapted to the volume of irradiated lesion. An
individual approach is possible using the additive technology of 3D printers for the production of
compensators. In radiotherapy, several uses of 3D print-outs have been reported in the literature, as boluses
in conventional therapy (Burleson et al 2015, Zou et al 2015, Canters et al 2016, Łukowiak et al 2016, Park
et al 2016, Oh et al 2017) and compensators in passively scattered beam PT (Ju et al 2014). Michiels et al
(2018) presented the benefits of using the compensator relative to the RS for PBS technology using Monte
Carlo (MC) simulations.
The question arises if the application of the compensator will influence patient exposure to secondary
radiation compared with conventionally applied RSs. EURADOSWorking Group 9 (Radiation Dosimetry in
Radiotherapy) in previous years has focused on the determination of scattered radiation doses generated
during treatment with modern radiotherapy techniques, using both photon and proton beams (Farah et al
2015, Mojżeszek et al 2017, Stolarczyk et al 2018). Particular attention was paid to paediatric patients treated
with protons, e.g. out-of-field doses in critical organs inside paediatric phantoms in Kneževíc et al (2018).
In this work, comprehensive measurements of out-of-field neutron and photon doses produced during
the treatment with PBS, were performed by EURADOSWG9. The measurements aimed at comparing the
scattered radiation doses for two types of pre-absorbers—a 4 cm thick RS made of Lexan (polycarbonate
resin thermoplastic), installed at the gantry scanning nozzle, as well as a 3D printed proton beam
compensator (BC) with a uniform thickness of 4 cm attached directly to the patient’s mask. The uniform
density of the printed BC was confirmed by the CT scan. The doses from secondary radiation received by
critical organs during irradiation of a superficial brain tumour, as well as the doses around the phantoms
were measured. Inside the phantoms, doses were determined with the same set of passive solid state detectors
as used in previous WG9 experiments: luminescent, track-etched and bubble detectors. Scattered radiation in
the therapy room was measured using different neutron monitors.
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2. Materials andmethods
2.1. Measurements conditions and prescribed doses
Measurements were performed at the Cyclotron Centre Bronowice (CCB IFJ PAN, Krakow) equipped with
an Ion Beam Application gantry (IBA Proton Therapy System—Proteus 235) with a dedicated scanning
nozzle. Experiments were carried out using two phantoms (see section 2.2)—corresponding to 5 and 10 yr
old children. For each phantom, two treatment plans were prepared using the Varian Eclipse treatment
planning system (version 13.6) with two types of pre-absorbers, RS and BC. As a target, a 6 cm diameter
sphere, shallowly located on the left-anterior side of the head with the isocentre in the middle of slice 3 (as
shown in figure 1 the supplementary data) was chosen, similar to that described in Majer et al (2017), but
with the target shifted towards the surface. The energies of layers were in the range from 80 to 140 MeV for
both phantoms. The spot size of beams, in terms of their sigma 12 value in air, measured at the distance of
46 cm from the nozzle surface (at the isocentre), ranged between 5.3 and 4.4 mm at beam energies 100 and
140 MeV, respectively. To obtain a uniform dose distribution in the target, two irradiation fields at gantry
angles of 0◦ (F1) and 90◦ (F2) were used. For both fields the source-to-surface distances were similar: 193.6
(F1), 194.6 (F2) and 193.7 (F1), 194.7 mm (F2) for RS and BC plans, respectively. The planned physical doses
to the target were: DT = 100 Gy for irradiation of luminescent dosimeters, DT = 40 Gy for track-etched
detectors and DT = 2 Gy for bubble detectors (BD), adapted to the sensitivity of detectors in the positions of
measurements. The doses correspond to DRBE = 110 Gy(RBE), DRBE = 44 Gy(RBE) and
DRBE = 2.2 Gy(RBE), respectively. Reference proton beam dosimetry was performed with a Marcus type
ionisation chamber (PTW) connected to a Unidos Webline electrometer (PTW).
2.2. Anthropomorphic paediatric phantoms
Anthropomorphic phantoms representing 5 and 10 yr old children (type 705D and type 706D, respectively)
were used for this study (ATOM, Computerized Imaging Reference Systems, Inc. Norfolk, VA, USA). The
phantoms consist of 26 and 32 slices for 5 and 10 yr old phantoms, respectively, with each slice 25 mm thick.
Slices are made of tissue equivalent material and divided into areas corresponding to individual organs,
where detectors can be inserted into holes of diameter 5 mm and fixed with appropriate plugs. There are 180
and 213 detector holes in the 5 and 10 yr old phantom, respectively. Based on phantom computed
tomography, the distance between all detectors and the isocentre located in the middle of the spherical target
was calculated. Mean organ doses in phantoms were estimated as the average dose measured by all passive
detectors placed in the particular organs. The brain doses were scored separately in the target volume
(defined as ‘Brain target’) to those outside (‘Brain non target’). Measured doses were normalized to the
physical target dose DT per 1 Gy. Moreover, because of the large sizes of BD and one type of track-etched
detectors, seven specially designed PMMA slices were used to replace the existing ones in the 5 yr old
phantom.
2.3. RS and compensator configuration
To obtain proton energies suitable for treating shallow lesions, two types of pre-absorbers were used. The
role of the pre-absorber is to degrade proton energies and shorten their path inside the patient’s body. The
RS dedicated for this purpose, included in the IBA Proteus-235 therapy system with 70 MeV minimal energy,
is a uniform slab of Lexan (C16H14O3, ρ= 1.2 g cm−3) material, with a thickness of 36.9 mm which
corresponds to 41.96 mm water equivalent thickness and consequently 1.14 water equivalent ratio (WER). In
the CCB facility, the RS is permanently attached to the nozzle, at a distance of 46 cm from the isocentre, and
can only be positioned in or out of the beamline (figure 1).
The second pre-absorber used in the experiment was an individually designed, personalized 3D printed
proton BC. The BC is placed directly on the mask to which it adheres due to the exact modelling of its shape
based on the patient’s CT images. Thus, an air gap between the pre-absorber and the patient is avoided
(figure 1).
For this experiment, individual compensators for two phantoms were printed. To be comparable to RS,
the thickness of the compensators was set at 4 cm and polylactic acid, PLA (C3H4O2, ρ= 1.2 g cm−3,
Fiberlogy S.A.) thermoplastic material was selected, whose WER equals 1.18 as calculated from
measurements. The Fused Filament Fabrication method was used for printing (Kuznetsov et al 2018). The
first step is heating the material to the temperature at which it liquefies (for PLA 240 ◦C) and the second step
is printing the model layer by layer. A layer thickness of 0.25 mm, a print path width of 0.8 mm and a nozzle
diameter of 0.8 mm were used. In addition, the printout was air-cooled throughout the entire printing
process.
12 The beam sigma is the single parameter characterizing the Gaussian shape.
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Figure 1. (A) Schematic view of active measurement positions (A)–(E) around the phantom with nozzle at 90◦ position. (B) RS
and BC configuration in the experiment.
2.4. Experimental setup
Phantoms were placed on the therapeutic table with its longer central axis perpendicular to the beam
direction. Passive dosimeters were placed inside the phantoms in the dedicated plugs except for BD and one
type of track-etched detector, which were placed in specially prepared PMMA slices. Active detectors
measuring neutron ambient dose equivalent H∗(10) were located at different angular positions around the
phantom and at various distances from the isocentre described in table 1 in the supplementary data
(available online at stacks.iop.org/PMB/66/035012/mmedia) and presented in figure 1. There were no active
detectors in the direction of the beam line. All detectors were located 1.25 m above the floor and aligned with
the horizontal plane. The selected setup is similar to previous EURADOSWG9 experiments (Farah et al
2015, Mojżeszek et al 2017). Active measurements were performed in parallel with the exposure of passive
detectors. Results were obtained for different doses, DT, i.e. 2, 40 and 100 Gy and renormalized to 1 Gy.
2.5. Active dosimetry inside the treatment room
Neutron ambient dose equivalent H∗(10) measurements were performed using five different neutron
monitors presented in this section, which—except REM-2 and GW2 ionization chambers—are described in
details in the previous EURADOSWG9 article (Stolarczyk et al 2018).
The REM-2 and GW2 chambers are cylindrical parallel-plate recombination chambers with an active
volume of about 1800 cm3. Description and operation modes of REM-2 and GW2 were presented in detail
by Zielczyński et al (2008) and Tulik et al (2018). The REM-2 is a chamber with a tissue equivalent electrodes
filled with tissue equivalent gas mixture, classified as a recombination chamber. Because the REM-2 chamber
approximates dosimetric parameters of the ICRU sphere (dose contribution and energy spectrum of
secondary charged particles at depth of 10 mm), H∗(10) can be determined for mixed radiation fields
(neutrons and photons) (Zielczyński et al 2008, Caresana et al 2014, Murawski et al 2018). To subtract the
photon dose component, the twin-detector method was used (Golnik et al 2014) and as a companion to
REM-2 the GW2 ionization chamber with aluminium electrodes and filled with CO2 was chosen. Due to its
construction, GW2 is almost insensitive to neutrons. The experimental set-up was calibrated against an
241Am–Be source at the accredited calibration laboratory in National Centre for Nuclear Research (NCBJ).
However, chambers were also tested in a high-energy reference radiation field (Mayer et al 2004), and energy
response of both detectors were determined in monoenergetic neutron reference fields (Golnik et al 1997) in
the National Physical Laboratory in Poland.
The Berthold LB 6411 (Burgkhardt et al 1997, Farah et al 2015) is a conventional 9.2 kg neutron meter
with a central 3He recoil proportional counter tube (10 cm length, 4 cm external diameter) and moderating
sphere of polyethylene (25 cm external diameter) and Cd absorbers.
The Wide Energy Neutron Detection Instrument second generation (WENDI-II) (Olsher et al 2000,
Farah et al 2015) is an improved 13.5 kg survey meter with a central 3He proportional tube counter
surrounded by cylindrical boron-doped polyethylene moderator (22.9 cm in diameter and 21 cm long).
Extending the energy range up to 5 GeV for neutrons was possible by using a tungsten powder shell (1.5 cm
in thickness) enclosing to the moderator.
Two Andersson–Braun neutron rem meters were used: a conventional NM2-458 and an extended-range
NM2B-495Pb model (NE Technology Ltd). They consist of a cylindrical BF3 boron trifluoride proportional
counter of 3.1 cm diameter and 7.2 cm active length surrounded by an inner moderating polyethylene layer
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(1.7 cm thick), a 0.6 cm thick boron-doped synthetic rubber absorber and an outer polyethylene moderator
(6.9 cm thick). The extension of the energy range in the NM2B-495Pb model was possible by adding a 1 cm
thick lead shell above the boron rubber.
The calibration factors for all instruments have been derived from irradiations with 241Am–Be source: the
Berthold by the manufacturer, WENDI-II, REM-2 and GW2 at the accredited calibration laboratory in NCBJ
and NM2B-458/NM2B-495Pb in Helmholtz ZentrumMünchen.
The overall measurement uncertainty for all devices contains mainly the uncertainties in detector
calibration, dose delivery, detector positioning and the energy response of the detectors. The last uncertainty
should take into account the wide range of neutron energies encountered in PT (from thermal to fast
neutrons), which together with the absence of neutron response functions for high energy neutron beams
(up to 300 MeV) makes this component very difficult to quantify. Nonetheless, the overall relative
measurement uncertainty is approximately 20% for the extended-range rem-counter (NM2B-495Pb)
(Mares et al 2002, Farah et al 2015) and WENDI-II detector (Olsher et al 2000, Farah et al 2015) and 30% for
standard rem-meters (REM-2, Berthold and NM2B-458) (Burgkhardt et al 1997, Farah et al 2015).
Detectors at the various positions, with their uncertainties and energy responses are presented in table 1
in the supplementary data.
2.6. Passive dosimetry methods used for in-phantommeasurements
Scattered photon beam radiation measurements were performed using radiophotoluminescence (RPL)
detectors. Secondary neutrons were determined using polyallyldiglycol carbonate based track-etched
(PADC) detector and BD, while the thermal neutron component was measured with a set of two types of
thermoluminescent (TL) detectors. Basic principles, characteristic and calibration procedures of these
passive dosimetry methods were described in previous EURADOSWG9 papers (Kneževíc et al 2013,
Miljaníc et al 2014, Stolarczyk et al 2018), but relevant information can be also found below. Types of
detectors, institutions that provided them and combined relative uncertainties are presented in table 2 in the
supplementary data.
2.6.1. Luminescence detectors used for out-of-field photon and neutron dosimetry
Two types of TL detectors in the form of pellets were used: MTS-7 (7LiF:Mg,Ti) and MTS-6 (6LiF:Mg,Ti),
both of which are based on a lithium fluoride matrix with magnesium dopants. All TL detectors were
calibrated using a 60Co source. The net difference between the readings of MTS-6 and MTS-7 was used to
calculate the gamma-equivalent neutron doses, Dn. RPL detectors (type GD-352M, manufacturer AGC
Techno Glass) in the form of small glass rods were used for photons measurements. Detectors used during
this experiment also contain an energy compensation filter and can be used for out-of-field dose
measurements, where scattered photons predominate. RPLs were calibrated in terms of kerma free-in-air,
Kair, using a 60Co source and then converted to Dw using experimentally determined factors (Kneževíc et al
2013). For determining the uncertainty of dose calculation for TLDs and RPLs, the same procedures were
used as presented in Kneževíc et al (2013, 2018) and Stolarczyk et al (2018). Particular calculated
uncertainties are presented in the table 2 in the supplementary data.
2.6.2. Track-etched and BD used for out-of-field neutron dosimetry
Nuclear Physics Institute Czech Academy of Sciences (NPI CAS) used PADC based (C12H18O7) track-etched
detectors type HARZLAS TD-1 (Nagase Landauer Ltd, Japan) with density 1.3 g cm−3. Detectors were cut
into 17 mm wide strips thick 0.9 mm. The neutron dose equivalent H was calculated based on the
relationship between the parameters of etched tracks and the particles’ LET (Jadrní̌cková et al 2008,
Pachnerová Brabcová et al 2013). Associated uncertainties include statistical uncertainties related to the
counting of particle tracks in different LET bins and systematic errors associated with uncertainties in
calibration curves. Here we combine both sources of uncertainty which lead to a total uncertainty of∼20%.
The uncertainty does not include the angular dependence of the track detector’s response (Ambrožová et al
2019).
Universitat Autònoma de Barcelona (UAB) has developed a dosimeter based on PADC track-etched
detectors (García et al 2005, Domingo et al 2013) with a layered structure described in detail by Domingo
et al (2013) and García et al (2005). These detectors were previously used in EURADOSWG9 experiments
and the procedure for reading the dose, based on MC simulation, was presented by Stolarczyk et al (2018)
and García-Fusté et al (2020). The neutron dose equivalent H was computed according to the Kerma
Approximation (therefore using the neutron fluence-to-kerma conversion coefficients kΦ(E) in ICRU
4-component tissue substitute (Chadwick et al 1999) and using the neutron quality factors Q(E) (Siebert and
Schuhmacher 1995)). From the experimental net track density per Gy, CPADC, the response function of the
whole dosimeter in terms of fluence RΦ(E) (Domingo et al 2013) and the MC unit spectral neutron fluence,
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φE (E). Based on that quantities, neutron dose equivalent, H, and neutron fluence, ΦPADC, can be evaluated.
This methodology has been already used and described by García-Fusté et al (2020). The main source of
uncertainty comes from the experimental uncertainty associated with the statistical counting of radiation in
the PADC layer. The uncertainties of the unit spectral neutron fluence come purely from the MC statistical
procedure. Relative uncertainties on the evaluated neutron dose equivalent ranges from 7% (near the proton
field) to 60% (far from the proton field).
BD, used for personal neutron dosimetry (Bubble Technology Industries) were used to measure neutrons
with energies above 200 keV. They are characterized by zero sensitivity to photons and are independent of
dose rate and energy response. Calibration was performed in a 252Cf field in the Secondary Standard
Dosimetry Laboratory of SCK CEN and applying the fluence-to-dose equivalent conversion factors obtained
from kerma factors for ICRU tissue (Siebert and Schuhmacher 1995). The uncertainty in the calibration and
therefore also the number of bubbles per dose equivalent is 20%, but also the positioning uncertainty of both
the phantom and detector should be taken into account, which is estimated at a maximum of 5%. By
combining the above sources, a total uncertainty of 25% was determined.
2.7. MC simulations
The aim of the MC simulations was to calculate the unit neutron spectral fluence φE (E), at the positions of
the PADC (UAB) detectors in the phantoms. which are required to calculate neutron dose equivalent from
the readings of the detector. MC simulations were performed using MCNPX (version 2.7.0) (Pelowitz 2011).
Composition and densities of the tissues of the voxelized phantom were taken from ICRU Report-44 report
(White et al 1989). A simplified beam model in the form of a parallel proton beam emitted from a disk of
6 cm in diameter was applied for calculation. In total 25 and 26 proton energies ranging from 80 to 140 MeV
were used for BC and RS, respectively. The source was located 46 cm from the isocentre inside the phantom
surrounded by air. In addition to pre-absorbers, no other room details were considered—their contribution
to the total neutron dose is not significant, which was confirmed by Mares et al (2016) through the
spectrometric in-room measurements where thermal neutrons contributed to 7%–24% of total fluence but
only 2% to dose equivalent. Unit neutron spectral fluence φE (E) were determined in spherical volumes of
0.5 cm diameter at the corresponding detector positions inside the phantom. In the simulations, no detectors
were placed at positions, so the disturbance of the neutron field were not included.
The cross sections libraries used in the MCNPX radiation transport were selected automatically
according to the pre-defined options in XSDIR file evaluated in 2013. Proton cross sections up to a proton
incident energy of 150 MeV were taken from ENDF/B-VII (.70h) (Chadwick et al 2006), but applied only for
pre-absorbers and their main components (C-12, O-16 and H-1). Because the voxelized phantoms in
simulations were represented by its natural composition, not the most abundant isotopes, inside the
phantom for the proton transport and neutron production the default configuration of the MC code was
employed (Bertini (Valentin 2003, Stolarczyk et al 2011)+ pre-equilibrium model+ Dresner (1981) with
RAL (Atchison, 1980) fission evaporation model). For all substances containing hydrogen inside the
phantom, the neutron thermal scattering effects due to H-1 are taken into account through the sublibrary
endf70sab (lwtr.10t), which also belongs to the library ENDF/B-VII.
Only transport of neutrons, protons and photons has been considered to be relevant when scoring the
unit neutron spectral fluence inside the phantom. Photonuclear reactions, as well as light ion rejection from
neutrons and protons were employed in simulations.
3. Results
All results are presented in µGy or µSv and normalized to the proton dose deposited in the centre of the
target, i.e. at the isocentre. Error bars were not included in plots of experimental results, for clarity.
3.1. Neutron ambient dose equivalentH∗(10) inside the treatment room
Mapping of stray neutron ambient dose equivalent H∗(10) was performed inside the treatment room.
Table 1 presents results as mean values of neutron dose equivalent normalized to total dose, H∗(10)/DT
(µSv Gy−1) measured for each field and phantom type on every position inside the treatment room. The
highest and the lowest values of 1.77 µSv Gy−1 in position B and 0.37 µSv Gy−1 in position D were noticed
for the 5 yr old phantom, nozzle angle 0◦ with RS as pre-absorber, and 10 yr old phantom, nozzle angle 90◦
with BC as pre-absorber, respectively. Generally, for all measurements, the lowest dose was measured in
position D, while the highest doses were observed at both positions A and B, for nozzle angles 90◦ and 0◦,
respectively. In most of the positions doses determined for RS irradiations are systematically higher than for
BC by 20%–30% but the uncertainty of measurements are of the same order. Moreover, higher ratios were
6
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Figure 2.Mean organ photon doses per target dose D̄P/DT and the ratios of RS/BC doses for RPL detectors for 5 and 10 yr old
phantom after irradiation with BC and RS. The exact values of the organ doses are presented in tables 3 and 4 in the
supplementary data. The uncertainties can be calculated as the uncertainty of the average value using values for particular
detectors from table 2 in the supplementary data.
observed for irradiations at the 90◦ nozzle position especially at positions B (1.69 vs. 1.08 for 5 and 10 yr
phantoms) and D (1.46 vs. 1.12 and 1.52 vs. 1.20 for 5 and 10 yr phantom, respectively).
3.2. Out-of-field photon doses inside the phantoms
The photon doses DP were measured by RPL detectors. Mean organ doses per target dose D̄P/DT (100 Gy)
and the ratios of RS/BC doses for both phantoms are presented in figure 2. The exact values of the organ
doses are presented in tables 3 and 4 in the supplementary data. The mean organ doses were calculated as the
arithmetic mean of doses from all detectors placed in the volume of the given organ. In most cases higher
organ doses for RS compared to BC are observed, especially for breasts and lungs. The opposite situation is
observed only for some distant organs as bladder and prostate in the 5 yr old phantom. For almost all organs,
RS/BC ratios are higher than 1, obtaining the highest ratio for breasts in both phantoms.
Out-of-field photon doses per target dose Dp/DT as a function of distance from the isocentre for both
phantoms are presented in figure 3. The graphs show that regardless of the distance from the isocentre, the
doses of out-of-field photons are lower for BC than for RS. For both types of detectors and pre-absorbers, a
similar trend can be observed, showing a reduction in photon doses by almost six orders of magnitude from
positions close to 5 cm (∼6E+05 µGy Gy−1) and up to 50 cm from the isocentre (∼2–3 µGy Gy−1). In the 5
and 10 yr phantoms the maximum of RS/BC ratios occurs at different distances from the isocentre due to the
different sizes of the phantoms.
3.3. Out-of-field neutron dose equivalent inside the phantoms
The neutron dose equivalent H was measured by BD, by a set of MTS-6/MTS-7 detectors and two types of
track-etched detectors. Figure 4 shows the neutron dose equivalent per target dose H/DT and the ratios of
RS/BC doses at different points and distances from the isocentre for the 5 yr old phantom, measured by BD
and PADC from UAB. The exact values of the organ doses are presented in table 5 in the supplementary data.
For these measurements it was necessary to use appropriate PMMA slices to hold the detectors. The
position number on the chart corresponds to the number of the replaced slice in the phantom, while letters F,
B, R, L and M indicate the position in the slice and mean: front, back, right, left and middle, respectively.
Except for two positions—15FR for PADC and 17FM for BD—in all other positions, higher doses for RS in
comparison with BC were observed. The highest RS/BC ratios at the distance between 20 and 30 cm from the
isocentre for both types of detectors are observed (10.2 and 2.6 for PADC and BD, respectively). At the
furthest three positions for irradiation with BC as the pre-absorber, the PADC detectors were under the
detection limit.
Results of TLD measurements for 5 yr old phantom are presented in figure 2 in the supplementary data
as the gamma-equivalent neutron dose per target dose Dn/DT. It was calculated as the net difference between
the readings of MTS-6 and MTS-7 detectors calibrated in terms of response to Co-60 gamma-rays. This
7



























































































































































































































































































































































































































































































Figure 3. Photon dose per target dose DP/DT and the ratios of RS/BC doses measured with RPL detectors in 5 (top) and 10 yr
(bottom) old phantom as a function of distance from the isocentre. The uncertainties can be assessed using values for particular
detectors from table 2 in the supplementary data.
difference is proportional to the thermal neutron fluence at the position of the detector (Stolarczyk et al
2018). The dose values obtained in this way require a conversion to be comparable with neutron doses
obtained by reading BD (see section 4.1. The correlation between gamma-equivalent neutron dose and dose
equivalent at the Discussion part).
Figure 5 shows mean neutron dose equivalent in organs per target dose H̄/DT measured with PADC
detectors for 10 yr old phantom, whilst the same results as a function of distance from the isocentreH/DT are
presented in figure 6. The exact values of the organ doses are presented in table 6 in the supplementary data.
It has been observed that for organs located near the isocentre, the measured neutron doses are higher for RS
than BC (e.g. for breasts 3.7 times), but for organs located at a greater distance, the relationship is reversed.
This is particularly visible on the graph showing doses as a function of distance from the isocentre—from a
distance of about 35 cm to over 60 cm, doses for BC are higher (for gallbladder 4.4 times or for intestine 3.8)
compared to RS. For organs closer to the isocentre, the measured doses were lower for BC. The highest
RS/BC ratio for the distance between 20 and 40 cm from the isocentre are observed with a maximum ratio of
9
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PADC (UAB): RS/PC ratio
Figure 4. Neutron dose equivalent per target dose H/DT and the ratios of RS/BC doses in particular position and distances from
the isocentre measured with BD and PADC (UAB) for RS and BC in the 5 yr old phantom. The exact values of the organ doses are
presented in table 4 in the supplementary data. The uncertainties can be assessed using values for particular detectors from table 2
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PADC (NPI CAS): BC
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-
Figure 5.Mean neutron dose equivalent in organs per target dose H̄/DT and the ratios of RS/BC doses for PADC (NPI CAS) for
RS and BC in the 10 yr old phantom. The exact values of the organ doses are presented in table 6 in the supplementary data. The
uncertainties can be calculated as the uncertainty of the average value using values for particular detectors from table 2 in the
supplementary data.
10.6. Such distances correspond to the positions of the lungs, breasts, liver and—for the 5 yr old phantom
only—stomach and intestine. The ratios at distances further than about 40 cm from the isocentre (which
corresponds to the positions of the liver, stomach, gallbladder, intestine, bladder and prostate) decreases
below unity. However, for such large distances the measured doses are relatively low (from 34.5 to
119.2 µGy Gy−1).
3.4. MC simulations
The unit neutron spectral fluence φE (E) was calculated with MC simulations at the positions of the PADC
(UAB) detectors in the 5y old phantom. Figure 7 shows the differences in the spectral neutron fluence,
ΦE(E)= ΦPADC · φE (E), where ΦPADC is the evaluated neutron fluence (see section 2.6) normalized to 1 Gy of
10
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10y PADC (NPI CAS): RS
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PADC (NPI CAS): RS/BC ratio
Figure 6. Neutron dose equivalent per target dose H/DT for PADC (NPI CAS) for RS and BC and the ratios of RS/BC doses in the
10 yr old phantom as a function of distance from the isocentre. The uncertainties can be assessed using values for particular
detectors from table 2 in the supplementary data.
Figure 7. Spectral neutron fluence, ΦE(E)= ΦPADC · φE (E) normalized to the unit dose at the isocentre in four positions inside
the 5y phantom (8FM, 11FM, 13FM and 17FM, see section 3.3) calculated with MC simulations.
the dose in the isocentre (40 Gy in total, based on measurements). Results present the spectral neutron
fluence for RS and BC at four different detector positions, at distances: 13.0 (8FM), 19.2 (11FM), 24.3
(13FM) and 35.1 cm (17FM) (abbreviations of positions names are described in section 3.3). It can be
observed that the contribution of thermal neutrons in the RS spectrum is bigger than in the BC spectrum at
each distance. Thermal neutrons do not significantly increase the dose equivalent in tissue, but they
predominately contribute to the response of MTS-6 detectors containing the Li-6 isotope. Moreover, the RS
spectra showmore high-energy neutrons generated at greater distances, than BC, which leads to higher doses.
To better illustrate the impact of geometry on the secondary neutrons measured inside the phantom,
from a subset of the total MC simulations we obtain a visualization of paths of neutrons, produced in
pre-absorber materials, was generated for the 0◦ nozzle angle (figure 8). The colour version allows secondary
neutrons to be distinguished according to their energy and shows that more high energy neutrons reach the
phantom and the critical organs volumes while using RS, than BC.
11
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Figure 8. Visualization of paths of neutrons, produced in two pre-absorbers (left—RS, right—BC), for the 0◦ nozzle angle.
4. Discussion
In this section the obtained results and the correlations between them are discussed. Additionally, the
reproducibility of measurements of active detectors were verified and the results are presented in the
supplementary data.
4.1. The correlation between neutron ambient dose equivalentH∗(10) and position around the phantom
Results of active measurements are presented for both pre-absorbers in table 1. In most of the positions doses
determined for RS irradiations are systematically higher than for BC by 20%–30%. This is because neutrons
produced in the compensator are directly attenuated in the phantom and deliver lower doses to distant
organs. In contrast, the RS placed 46 cm from the isocentre produces a neutron shower which leads to
exposure of the entire phantom. Higher ratios of RS/BC values were observed for irradiations at the 90◦
nozzle position especially at positions B (1.69 vs. 1.08 for 5 and 10 yr phantoms) and D (1.46 vs. 1.12 and
1.52 vs. 1.20 for 5 and 10 yr phantom, respectively). At position B, where the differences are the largest, it
should be noticed, that for the nozzle angle 0◦ the detector recorded twice higher dose for BC, while for RS
only higher by about 20% comparing with the doses detected for nozzle angle 90◦. This disproportionality
may be caused by the fact that while the nozzle is at the angle 90◦ the gantry arm partly covered the detector
and crossed the neutron path line between the compensator and the detector, thus absorbing and scattering
some neutrons. Higher doses were also observed at positions C and E than at position D, although these
detectors are located at the same distance from the isocentre. At positions C and E, detectors with extended
energy range were positioned, while the detector on position D detects neutrons in the energy range from
thermal to 14 MeV (see table 1 in the supplementary data). Detectors with an extended energy range absorb
neutrons with energy higher than 14 MeV, which resulted in a higher neutron dose equivalent. It is also
worth emphasizing that the dose equivalent at position D is around 25 µSv per 50 Gy target dose during the
entire treatment course.
4.2. Comparison of out-of-field doses measured with RS and BC
A comparative analysis of the results for RS and BC was made by presenting the ratios RS/BC for both
photon and neutrons doses. Significantly higher photon organ doses were observed for the breast using RS
(figure 2) than BC, which may result from the superficial location of the detectors—the dose for the breast is
recorded by two shallowly located dosimeters placed at chest height. A secondary photons shower generated
in the RS reaches the phantom surface through the air gap, while that generated in the BC immediately
interacts with subsequent internal phantom structures, thus limiting the possibility of wide-angle dispersion.
A similar relationship is observed at many points located close to phantom surfaces at a distance from 20 to
40 cm. Considering the previously mentioned effect of the air gap, it can be concluded that a higher ratio of
RS/BC doses is observed at a closer position of the detector relative to the phantom surface. It is worth noting
that the calculated distance from the isocentre does not provide unambiguous information about the
location of the measuring point relative to the phantom edges—a distance of 30 cm from the isocentre may
correspond to a detector located both at a depth of 10 and 2 cm. Similar results, i.e. the highest ratios of
12




















































Figure 9. Neutron dose equivalent per target dose H/DT measured with bubble detectors BD and neutron dose equivalent derived
from the TLDs measurement (MTS-6-MTS-7) for 5 yr old phantom as a function of distance from the isocentre.
RS/BC doses for the distance between 20 and 30 cm from the isocentre are observed for secondary neutrons
(figures 4 and 6). Such distances correspond to the positions of the lungs, breasts, liver and—for the 5 yr old
phantom only—stomach and intestine. This may be again due to the lower attenuation of secondary
neutrons in the air gap before reaching the phantom, as compared to BC. For neutron doses recorded by
PADC detectors from NPI CAS, it has been observed that ratios of RS/BC doses at distances further than
about 40 cm from the isocentre (which corresponds to the positions of the liver, stomach, gallbladder,
intestine, bladder and prostate) decrease below unity. However, for such large distances the measured doses
are relatively low (from 34.5 to 119.2 µSv Gy−1), so their influence on exposure of children is much lower.
4.3. The correlation between gamma–equivalent neutron dose and dose equivalent
Pairs of 6LiF/7LiF thermoluminescence detectors are used in dosimetry to discriminate between neutron and
gamma-ray doses. The difference in response between 6LiF and 7LiF detectors, caused by the higher 6Li cross
section in the Li(n,α)T reaction, is expressed in terms of the gamma-equivalent neutron dose, Dn (Kneževíc
et al 2018). However, this quantity cannot be used to infer neutron dose equivalent because the dose in tissue
is predominately produced by high energy neutrons whereas 6Li reacts mainly with thermal neutrons. In a
previous EURADOS experiment, dosimetric measurements of a scattered proton beam were performed in a
30 cm× 30 cm× 60 cm water phantom using PADC, calibrated in terms of neutron dose equivalent and
pairs of MTS-6/MTS-7 detectors (Stolarczyk et al 2018). The conversion coefficient relating the PADC (UAB)
detectors and net signal of TLD varied between 0.3 and 0.7 mSv mGy−1, depending on the position in the
phantom. For the current measurements, the best agreement with the readouts of PADC was obtained for
the conversion coefficient 0.9 mSv mGy−1. The presence of pre-absorbers changes the neutron energy
spectrum, which has an impact on the conversion coefficient. For such converted results, a comparison with
BD and results from a previous experiment with the same conditions (but without a pre-absorber) from
Kneževíc et al (2018) is presented in figure 9. As expected, neutron doses are lowest for irradiation without
any pre-absorber.
4.4. Understanding neutron energy spectra
The spectral neutron fluence presented in figure 7 depends on the position of the pre-absorber relative to the
phantom. Secondary neutrons are produced and spread in the pre-absorber material. Due to the fact, that
the RS is 46 cm from the target, while the BC is on the phantom surface, the angles between the pre-absorber,
as the source of the neutron beam, and the detectors located inside the phantom are about 10◦–40◦ for RS
and almost 80◦–90◦ for BC. Therefore, in such geometry more neutrons can be observed inside the phantom
for RS than for BC. This impact of the geometrical set up is presented in figure 8. Moreover, the colour
coding of this figure shows, that high energy neutrons (above 10 MeV) are produced in the forward
direction, while low energies neutrons (below 10 MeV) appear to be isotropic. This leads to conclusions that
more of high energy neutrons reach the phantom and the critical organs volumes while using RS, than BC,
because of the larger distance from the phantom surface.
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Distance from isocentre [cm]
upper/lower empirical range (IMRT) (Kry 2017)
5y - IMPT (RS)
5y - IMPT (BC)
5y - 3D CRT (Majer 2017)
5y - IMRT (Majer 2017)
5y - IMPT (no-preabs) (Knežević 2018)
Figure 10. Out-of-field photon dose per target dose Dp/DT inside the phantom measured by RPL detectors for all three
experiments (Majer et al 2017, Kneževíc et al 2018) for 5 yr old phantom presented as a function of distance from the isocentre.
The upper and lower bounds (solid curves) presented the empirical range of doses associated with different IMRT techniques,
presented by Kry et al (2017).
4.5. Comparison with data from literature
The results were compared with the literature data presented in Majer et al (2017) and Kneževíc et al (2018)
collected in other EURADOSWG9 experiments with the same phantoms, tumour size and locations. In
Majer et al (2017) two different treatment techniques based on x-ray radiotherapy, i.e. 3D conformal
radiation therapy (3D CRT) and intensity modulated radiation therapy (IMRT) were used, while in Kneževíc
et al (2018) the experiment was performed in the same PT facility (CCB IFJ PAN), so intensity modulated PT
(IMPT) treatment technique was used. The results showed by Kneževíc et al (2018) represent cases of these
paediatric tumours, such as base-of skull tumours, which are situated deeper and should be treated without
pre-absorbers to avoid an additional beam scattering. The target diameter in all experiment was the
same—6 cm. Out-of-field photon doses per target dose DP/DT inside the phantom measured by RPL
detectors for all three experiments for a 5 yr old phantom are presented as a function of distance from the
isocentre in figure 10. In the vicinity of the isocentre, i.e. at a distance of 10–15 cm, doses from secondary
photons were recorded at a similar level (excluding doses for 3D CRT), while at a depth of 30 cm, secondary
doses for IMRT and 3D CRT are one and two orders of magnitude higher than for RS and BC, respectively.
Both doses for 3D CRT and IMRT are close to IMPT only in the vicinity of the isocentre, while at a distance
of about 10 cm doses are higher by one and even two orders of magnitude at further distances, especially
comparing to IMPT with the BC as a pre-absorber. Moreover, comparison with IMPT irradiation without
any type of a pre-absorber (Kneževíc et al (2018)) showed higher photon doses at a distance from 20 to
40 cm for irradiations with RS, remaining comparable for closer and further distances. Doses for irradiation
with the use of a BC can be considered, within the limits of uncertainty, to be consistent with doses obtained
without a pre-absorber, but a slight but systematic shift and thus lower doses for irradiations without a
pre-absorber can be observed. Similar relationships were observed for a 10 yr old phantom (not presented in
the figure 10, for clarity). The obtained results were also compared with the empirical range of doses
associated with different IMRT techniques, presented by Kry et al (2017).
Neutron dose equivalent was also measured by Kneževíc et al (2018) using the same type of
detectors—BD and PADC for a 5 yr old phantom. Such results were compared with neutron doses obtained
for RS and BC at the same distances (13, 20 and 30 cm) for a 5 yr old phantom, which is presented in table 2.
The obtained results are higher for closer distances, levelling out at a distance of about 30 cm, which is the
expected result due to the presence of a pre-absorber. Similar measurements were made by Hälg et al (2014)
for proton PBS inside the anthropomorphic RANDO phantom. Considering the differences between these
two experimental setups (phantom and target size, proton field parameters and set up) these results are in
good agreement.
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Table 2. Neutron dose equivalent per target dose H/DT (µSv Gy−1) as a function of distance from the isocentre for BD and PADC
(UAB) for a 5 yr old phantom—comparison with literature data (Hälg et al 2014, Kneževíc et al 2018). The uncertainties for BD and
PADC (UAB) detectors can be assessed using values for particular counters in table 2 in the supplementary data, while for results in Hälg
et al (2014) the standard uncertainty of 28% was used.




BD comparison PADC (UAB) comparison Track-etched detectors
RS BC Kneževíc et al (2018) RS BC Kneževíc et al (2018) Hälg et al (2014)
13 195 133 130 280 226 130 ∼500–600
20 57 46 30 107 48 50 —
30 32 12 — 29 33 15 ∼70
5. Conclusions
This paper reports the results of an experiment to determine the out-of-field doses during PBS irradiation of
shallowly located tumours in children. Two treatment approaches with the use of additional proton energy
pre-absorbers were considered. Radiation doses in the 5 and 10 yr anthropomorphic phantoms and in the
treatment room were determined for two types of pre-absorbers—an RS and a personalized 3D printed
proton BC. The main purpose of this comparison was to check the impact of the latter on the scattered
radiation doses compared with conventionally used RSs.
The results confirmed that the use of BC as the pre-absorber does not significantly increase and in many
cases slightly decreases these out-of-field-doses while being highly useful during the treatment of shallow
lesions. Considering and summarizing all the results and comparing the measured doses for RS and BC it is
concluded that the use of personalized 3D printed proton compensator be can be safely used for paediatric
patients.
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